
Integrating EudraVigilance Data Into Signal Management: How to Choose the Right Approach
Explore three ways to integrate EudraVigilance data into signal management, from validation and evaluation to risk-based detection and monitoring.
Read moreExpert guidance across pharma, biotech, and medical devices — stay ahead of industry trends and best practices.

Explore three ways to integrate EudraVigilance data into signal management, from validation and evaluation to risk-based detection and monitoring.
Read more
Regulation (EU) 2025/1466 changes EU signal management and EudraVigilance monitoring. Learn what MAHs need to implement and document.
Read more
Revision 2 of GVP Module III reinforces subcontractor oversight, immediate PSMF availability, risk-based inspection cycles and remote inspection readiness. Here is what MAHs, QPPVs and pharmacovigilance providers need to know.
Read more
Discover why Medical Information and Pharmacovigilance integration is essential for safety reporting, compliance, efficiency and audit readiness.
Read more
Medical inquiry volumes are rising as products, patient expectations and regulatory requirements grow more complex. Is your Medical Information model ready?
Read more
Discover how AI is transforming Medical Information, why regulators are increasing oversight, and how pharma companies can prepare for a future-ready MI operating model.
Read more
Discover how automation bias in AI-supported SAE and SUSAR workflows can lead to missed expedited reporting obligations and increased pharmacovigilance risk.
Read more
Learn how sponsors and CROs can govern AI in SAE and SUSAR management through human oversight, explainability, validation, and regulatory compliance.
Read more
Discover how AI supports safety surveillance in medical device and combination product trials, and what sponsors must consider for governance and compliance.
Read more
Discover how pharmaceutical companies can manage Regulatory Affairs and Pharmacovigilance across multiple markets through scalable Lifecycle Management and integrated governance.
Read more
Acquiring or licensing new pharma products introduces complexity across RA and PV. Learn how a structured Lifecycle Management framework helps maintain compliance and control during integration.
Read more
Entering the EU market requires more than approval. Discover the pharmacovigilance, quality, and MAH requirements biotechs must prepare before European launch.
Read more
Expanding across Europe introduces complex pharmacovigilance requirements. Learn how EU PV systems can scale while integrating national roles and regulatory obligations.
Read more